|
TDP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.521590E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.261950E-01 |
| Normal-vs-Stage2 |
4.904000E-01 |
| Normal-vs-Stage3 |
2.277200E-03 |
| Normal-vs-Stage4 |
3.663000E-03 |
| Stage1-vs-Stage2 |
8.444200E-01 |
| Stage1-vs-Stage3 |
5.126400E-02 |
| Stage1-vs-Stage4 |
7.190400E-02 |
| Stage2-vs-Stage3 |
2.285000E-01 |
| Stage2-vs-Stage4 |
1.802210E-01 |
| Stage3-vs-Stage4 |
7.121200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.485500E-02 |
| Normal-vs-AfricanAmerican |
3.71789999999983E-05 |
| Normal-vs-Asian |
3.758200E-02 |
| Caucasian-vs-AfricanAmerican |
8.958000E-04 |
| Caucasian-vs-Asian |
6.325600E-02 |
| AfricanAmerican-vs-Asian |
8.289800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.240100E-02 |
| Normal-vs-Female |
1.770630E-01 |
| Male-vs-Female |
2.458600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.144300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.945200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.985800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.394790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.437800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.206000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.381200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.069900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.508000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.278200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.369200E-01 |
| Normal-vs-Grade 2 |
3.344400E-01 |
| Normal-vs-Grade 3 |
1.094060E-02 |
| Normal-vs-Grade 4 |
1.589960E-04 |
| Grade 1-vs-Grade 2 |
6.218400E-01 |
| Grade 1-vs-Grade 3 |
1.460190E-01 |
| Grade 1-vs-Grade 4 |
2.804300E-02 |
| Grade 2-vs-Grade 3 |
9.553600E-02 |
| Grade 2-vs-Grade 4 |
1.701960E-03 |
| Grade 3-vs-Grade 4 |
2.474000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.979000E-01 |
| Normal-vs-ccB subtype |
4.96950000039575E-08 |
| ccA subtype-vs-ccB subtype |
1.15510045972655E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.621800E-02 |
| Normal-vs-N1 |
1.675900E-03 |
| N0-vs-N1 |
5.389900E-02 |
|
|
